欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
Gemcitabine (elaidate)_210829-30-4_产品详情
210829-30-4
  • Gemcitabine (elaidate)

  • names:

    Gemcitabine (elaidate)

  • CAS号:

    210829-30-4

    MDL Number:
  • MF(分子式): C27H43F2N3O5 MW(分子量): 527.64
  • EINECS: Reaxys Number:
  • Pubchem ID: Brand:BIOFOUNT
Gemcitabine (elaidate)
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
YZM001391-10mg 10mg 99.24% ¥ 1957.50 ¥ 1957.50 2-3天
- +
¥ 0.00
YZM001391-5mg 5mg 99.24% ¥ 1365.00 ¥ 1365.00 2-3天
- +
¥ 0.00
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名
英文别名 Gemcitabine (elaidate)
CAS号 210829-30-4
Inchi
InchiKey
分子式 Formula C27H43F2N3O5
分子量 Molecular Weight 527.64
溶解度Solubility 生物体外In Vitro:DMSO溶解度≥ 26 mg/mL(49.28 mM)H2O< 0.1 mg/mL(insoluble)*"≥" means soluble可溶, but saturation unknown溶解度未知.
性状
储藏条件 Storage conditions 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月
产品说明
IntroductionGemcitabine elaidate(CP126; CO01) is a lipophilic, unsaturated fatty acid ester derivative of gemcitabine (dFdC), an antimetabolite deoxynucleoside analogue, with potential antineoplastic activity. IC50 value:
Application1
Application2
Application3
Gemcitabine elaidate(CP-4126; CO-101) is a lipophilic, unsaturated fatty acid ester derivative of gemcitabine (dFdC), an antimetabolite deoxynucleoside analogue, with potential antineoplastic activity. IC50 value: Target: Gemcitabine analog Upon hydrolysis intracellularly by esterases, the prodrug gemcitabine is converted into the active metabolites difluorodeoxycytidine di- and tri-phosphate (dFdCDP and dFdCTP) by deoxycytidine kinase. dFdCDP inhibits ribonucleotide reductase, thereby decreasing the deoxynucleotide pool available for DNA synthesis; dFdCTP is incorporated into DNA, resulting in DNA strand termination and apoptosis. Due to its lipophilicity, gemcitabine 5'-elaidic acid ester exhibits an increased cellular uptake and accumulation, resulting in an increased conversion to active metabolites, compared to gemcitabine. In addition, this formulation of gemcitabine may be less susceptible to deamination and deactivation by deoxycytidine deaminase. Check for active clinical trials or closed clinical trials using this agent.
警示图
危险性
危险性警示
安全声明
安全防护
备注
    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻
        抱歉,暂无数据!
        My title page contents